243.36

4.36% 10.16

After Hours: 243.36

Tenet Healthcare Corp (THC)

Overview News Price History Option Chain Financials Why THC Down? Discussions Forecast Stock Split Dividend History

Tenet Healthcare Corp stock is traded at $243.36, with a volume of 2.22M. It is up +4.36% in the last 24 hours and up +28.76% over the past month. Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Previous Close:

$233.20

Open:

$238.48

24h Volume:

2.22M

Relative Volume:

1.46

Market Cap:

$20.96B

Revenue:

$21.46B

Net Income/Loss:

$2.65B

P/E Ratio:

12.65

EPS:

19.2312

Net Cash Flow:

$3.35B

1W Performance:

+25.20%

1M Performance:

+28.76%

6M Performance:

+28.66%

1Y Performance:

+59.04%

1-Day Range:

$234.23

$248.82

1-Week Range:

$191.26

$248.82

52-Week Range:

$151.00

$248.82

Tenet Healthcare Corp Stock (THC) Company Profile

Name

Tenet Healthcare Corp

Sector

Healthcare (1074)

Industry

Medical Care Facilities (50)

Phone

469-893-2200

Address

14201 DALLAS PARKWAY, DALLAS, TX

Employee

99,000

Twitter

@tenethealth

Next Earnings Date

2026-07-24

Latest SEC Filings

THC's Discussions on Twitter

Compare THC vs HCA, DVA, FMS, EHC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
THC Tenet Healthcare Corp	243.36	20.09B	21.46B	2.65B	3.35B	19.23
HCA Hca Healthcare Inc	389.62	84.78B	76.39B	7.81B	7.93B	29.08
DVA Davita Inc	236.31	15.11B	13.84B	1.10B	1.49B	10.42
FMS Fresenius Medical Care Ag Adr	24.87	13.21B	22.44B	1.35B	2.03B	1.9002
EHC Encompass Health Corp	113.88	11.20B	6.07B	793.80M	464.40M	5.9914

Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-14-25	Resumed	Goldman	Buy
Jul-28-25	Downgrade	Wolfe Research	Outperform → Peer Perform
May-29-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-26-25	Initiated	Morgan Stanley	Overweight
Feb-26-25	Initiated	TD Cowen	Buy
Dec-17-24	Resumed	JP Morgan	Overweight
Dec-16-24	Downgrade	Goldman	Buy → Neutral
Nov-25-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Nov-22-24	Downgrade	Raymond James	Strong Buy → Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-27-24	Upgrade	Wolfe Research	Peer Perform → Outperform
Mar-06-24	Initiated	Barclays	Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Apr-19-23	Initiated	JP Morgan	Overweight
Jun-17-22	Initiated	Loop Capital	Buy
Mar-29-22	Initiated	Wells Fargo	Overweight
Feb-10-22	Upgrade	UBS	Neutral → Buy
Feb-09-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Feb-09-22	Upgrade	Truist	Hold → Buy
Jan-20-22	Upgrade	Raymond James	Outperform → Strong Buy
Jan-10-22	Resumed	Citigroup	Buy
Sep-27-21	Initiated	SVB Leerink	Mkt Perform
Sep-24-21	Initiated	UBS	Neutral
Aug-12-21	Upgrade	Barclays	Equal Weight → Overweight
Jul-23-21	Resumed	Citigroup	Buy
Jul-09-21	Initiated	Seaport Global Securities	Buy
May-03-21	Resumed	Goldman	Buy
Jan-08-21	Upgrade	Jefferies	Hold → Buy
Jan-05-21	Upgrade	BofA Securities	Neutral → Buy
Dec-15-20	Upgrade	Deutsche Bank	Hold → Buy
Sep-21-20	Downgrade	JP Morgan	Neutral → Underweight
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Feb-26-20	Upgrade	JP Morgan	Underweight → Neutral
Dec-09-19	Upgrade	UBS	Neutral → Buy
Nov-06-19	Upgrade	Credit Suisse	Neutral → Outperform
Aug-14-19	Resumed	Goldman	Neutral
Feb-26-19	Reiterated	BofA/Merrill	Neutral
Jan-14-19	Initiated	Stephens	Equal-Weight
Jan-03-19	Initiated	Deutsche Bank	Hold
Dec-17-18	Downgrade	Robert W. Baird	Outperform → Neutral
Nov-16-18	Initiated	UBS	Neutral
Jun-29-18	Downgrade	Jefferies	Buy → Hold
Mar-23-18	Resumed	Mizuho	Buy
Jan-30-18	Resumed	Wells Fargo	Market Perform
Jan-03-18	Initiated	Goldman	Neutral
Dec-20-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-19-17	Reiterated	Mizuho	Neutral
Dec-14-17	Downgrade	JP Morgan	Neutral → Underweight
Dec-12-17	Upgrade	Citigroup	Neutral → Buy

View All

Tenet Healthcare Corp Stock (THC) Latest News

Jul 27, 2026

THC Maintained by TD Cowen -- Price Target Raised to $263 - GuruFocus

Jul 27, 2026

Exchange-to-Uninsured Moves in Q2 Far Outpaced Hospital Executives’ Expectations - HCI Innovation Group

Jul 27, 2026

Raymond James raises Tenet Healthcare stock price target on strong Q2 results - Investing.com

Jul 27, 2026

THC Maintained by RBC Capital -- Price Target Raised to $283 - GuruFocus

Jul 27, 2026

THC Maintained by UBS -- Price Target Raised to $308 - GuruFocus

Jul 27, 2026

THC (THC) affiliate files to sell 10,878 common shares under Rule 144 - Stock Titan

Jul 27, 2026

Form 144 TENET HEALTHCARE CORP For: 27 July By Investing.com - Investing.com South Africa

Jul 27, 2026

Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook - Yahoo Finance

Jul 27, 2026

Tenet Healthcare stock hits all-time high at 247.44 USD - Investing.com

Jul 27, 2026

THC Maintains Rating by Morgan Stanley -- Price Target Raised to $274 - GuruFocus

Jul 27, 2026

Tenet Healthcare (THC) insider plans $1.22M sale of 5,000 shares - Stock Titan

Jul 27, 2026